Abivax is a clinical-stage biopharmaceutical company based in Paris, France, that develops oral therapies for inflammatory and immune-related conditions. Its main investigational product is an orally administered small molecule being studied for ulcerative colitis and other inflammatory diseases. The company's work is aimed at patients with chronic inflammatory disorders and at the physicians who treat them, and it also has earlier-stage research programmes in antiviral and immune areas.
Abivax S.A. trades under the code 0RA9 on the London Stock Exchange in UK, with its price quoted in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3342 of 3788 on the London Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
17/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-19.5%
From 52-week high-41.2%
MomentumWeak
24/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-29.1%
6-month return-17.3%
12-month, skipping last month-0.1%
Stability (higher is calmer)Weak
15/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)86.9%
Worst drawdown, 1 year (smaller is calmer)-48.0%
LiquidityWeak
43/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.35M EUR
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 60.70 – 139.00Daily closes, split-adjusted
Signals
50-day average89.24
200-day average99.25
Golden/death cross (60d)Death, 21 days ago
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)3.34
Technical summary
Daily
Strongly bearish
1 bullish · 4 neutral · 11 bearish
Weekly
Bearish
3 bullish · 1 neutral · 8 bearish
Monthly
Neutral
4 bullish · 1 neutral · 3 bearish
Moving averages (daily)
SMA 10
80.29
Bearish
EMA 10
80.18
Bearish
SMA 20
80.45
Bearish
EMA 20
81.62
Bearish
SMA 50
89.24
Bearish
EMA 50
88.00
Bearish
SMA 100
97.81
Bearish
EMA 100
93.38
Bearish
SMA 200
99.25
Bearish
EMA 200
92.54
Bearish
Oscillators (daily)
RSI (14)
44.19
Neutral
MACD (12, 26)
-2.58
Bearish
Momentum (12)
0.06
Bullish
Stochastic %K (14)
54.76
Neutral
Williams %R (14)
-45.24
Neutral
CCI (20)
-37.17
Neutral
Pivot points (classic, last session)
S3
75.67
S2
76.53
S1
78.22
Pivot
79.08
R1
80.77
R2
81.63
R3
83.32
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
